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& To evaluate seroprevalence of B. henselae infection both in Sicilian children and healthy
blood donors. Furthermore, circulation of Bartonella in the natural reservoir was also studied.
Two hundred forty-three children, living in Sicily (Palermo), affected by various diseases, without
clinical features suggesting B. henselae infection, together with 122 healthy blood donors were
serologically investigated for IgG and IgM antibodies by indirect fluorescent antibody test (IFAT).
One hundred twenty stray and 62 pet cats were also analyzed only for IgG. Among children 25.1%
had IgG antibodies to B. henselae; 18.5% showed a titer 1:64, 2.4% 1:128, 2.4% 1:256, 0.8%
1:512, 0.4% 1:1024, and 0.4% 1:5120. Among healthy blood donors 11.4% had IgG class anti-
bodies to B. henselae; 9.8% showed a titer 1:64 and 1.6% 1:128. All the human serum samples
did not show positive results for B. henselae IgM class antibodies. Stray cats (68.3%) and pet cats
(35.4%) also had IgG class antibodies to B. henselae. We demonstrated high frequency of sero-
logic evidence of past B. henselae infection, in young Italian children, affected by various dis-
eases, apparently free of any clinical features suggesting B. henselae infection. This
observation is supported by high circulation of Bartonella in cats.
Keywords Bartonella henselae, cat scratch disease, indirect fluorescent antibody test
Address correspondence to Pasquale Mansueto, Dipartimento di Medicina Clinica e delle
Patologie Emergenti, University of Palermo, Via del Vespro, 141-90146 Palermo, Italy. E-mail:
mansueto@unipa.it
Journal of Immunoassay and Immunochemistry, 33:18–25, 2012
Copyright # Taylor & Francis Group, LLC
ISSN: 1532-1819 print/1532-4230 online
DOI: 10.1080/15321819.2011.591476
D
ow
nl
oa
de
d 
by
 [T
&F
 In
ter
na
l U
se
rs]
, [
ca
rl 
he
igh
es
] a
t 0
3:3
7 0
3 J
an
ua
ry
 20
12
 
INTRODUCTION
Bartonella (B.) henselae infection is a common zoonosis, with worldwide
distribution. Bacterial infection caused by B. henselae is the most common
cause of a benign regional lymphadenopathy, known as ‘‘cat scratch
disease’’ (CSD), in children and young adults.[1–3]
The availability of a sensitive immunofluorescence assay has significantly
increased our awareness of human clinical manifestations of B. henselae
infection, allowing identification, particularly in children, of new clinical
features, such as distal ileitis, mimicking Crohn disease, and pseudoinfec-
tious mononucleosis.[4–6] While most cats infected by B. henselae never
develop detectable clinical signs of disease, the spectrum of B. henselae–
associated illness, in diseased cats, comprises self-limiting febrile illness,
lymphadenopathy, mild to moderate transient anemia, and transient neuro-
logic dysfunction.[7]
Human and cat seroprevalence of antibodies to B. henselae may differ,
considerably, in different geographic regions, and among individuals living
in the same geographic area.[1,8–10] There currently are not clear data
about the prevalence of human symptomatic B. henselae infection, because
it is often underdiagnosed, but there are consistent data on the seropreva-
lence of B. henselae both in humans[11–14] and in feline populations.[15,16]
In this report we carried out a retrospective evaluation of the seropreva-
lence (IgG and IgM antibodies against B. henselae) in 243 children, living in
Sicily, affected by various diseases, who were apparently free of any clinical
features suggesting B. henselae infection. The same analysis was done in 122
healthy blood donors, not gender- and age-matched, from the same geo-
graphic area. Furthermore, we have studied the circulation of Bartonella
in the natural animal reservoir (cats) by detecting IgG B. henselae antibodies
in 120 stray and 62 pet cats, living in the same geographic area.
MATERIALS AND METHODS
Subjects
We analyzed IgG and IgM antibodies to B. henselae in serum samples,
stored at 20C, taken from 243 children, living in Sicily, affected by vari-
ous diseases (bacterial and viral infections, neoplasms, and inflammatory
and metabolic diseases), who were, randomly, observed during February
2004–February 2005, as in- and outpatients, at the Children Hospital of
Palermo (Italy). One hundred twenty-four were male, and 119 were female.
The age range was 2 months to 14 years (mean age 8.3 2.5 years).
Ninety-six patients out of 243 underwent clinical examination for
growth control (general health status check-up) and for minor illness, such
Prevalence of Antibodies Anti-Bartonella henselae 19
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as upper respiratory tract infection. Forty-eight were affected by metabolic
diseases (i.e., type 1 diabetes mellitus), 33 by nephrologic disease (i.e.,
acute renal failure and glomerulonephritis), 26 by infectious disease (i.e.,
lower respiratory tract infection and acute gastroenteritis), 16 by neoplasms
(i.e., leukemia=lymphoma), 14 by immunologic disease (i.e., primary
immunodeficiency), and, finally, 10 by a pathology requiring surgical inter-
vention (i.e., acute appendicitis).
No patients had clinical features specifically suggesting B. henselae
infection, including subacute lymphoadenopathy. Informed consent for
collection of additional blood samples was given by each patient’s parent(s).
We also examined serum samples for IgG and IgM antibodies to
B. henselae, stored at 20C, taken from 122 healthy blood donors, not
gender- and age-matched, selected from the Blood Bank of our Department.
Seventy-five were male, and 47 were female. The age range was 18–56 years
(mean age 29.5 8.1 years). No subjects had clinical features specifically
suggesting B. henselae infection, including subacute lymphoadenopathy.
We also studied serum samples, stored at 20C, taken from 120 stray
cats, living in urban stray-cat colonies, and 62 pet cats, living in private homes,
in the same area of our human population, to evaluate the circulation of
Bartonella in the natural reservoir by detecting IgG B. henselae antibodies.
Immunofluorescence Assay
All serum samples were examined by indirect fluorescent antibody test
(IFAT) for the presence of IgG and IgM class antibodies to B. henselae.
For antigens, we used our in-house prepared slides to increase the test
sensitivity.[17] Slides were prepared by using B. henselae strain Houston-1 as
antigen, obtained from the collection of the National Reference Center of
Rickettiosis, Marseille, France. Briefly, bacteria were grown in a VERO cell
line for 2 weeks, then infected cells were recovered and lysed by sonication.
Cell suspensions were centrifuged at 1,500 rpm (700 g) for 10min to
remove cell debris, and bacteria were purified by using a sucrose gradient
[phosphate-buffered saline (PBS) with 25% sucrose (BioMe´rieux, Marcy-
l’Etoile, France)]. The resulting pellet was washed in PBS twice (6,000 g
for 10min), and purified bacteria were pelleted by centrifugation
(10,000 g for 10min), resuspended in sterile distilled water, and stored
at 80C before use. This whole-cell antigenic preparation was plated onto
microscopy slides for immunofluorescence (BioMe´rieux, Marcy-l’Etoile,
France) and used for detection of IgG and IgM antibodies by IFAT.
For the IFAT, the slides were stained for 30min, at 25C, in thermostat,
in humid chamber, with 10mL of the serum, diluted in PBS 1:64 for IgG
and 1:20 for IgM, respectively, for human samples, and 1:64 for IgG for
20 P. Mansueto et al.
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cat samples. Slides were then washed twice in PBS (pH 7.2, for 5min), and
then briefly rinsed with distilled water. After being air dried, slides were
incubated for 30min, at 37C, in thermostat, in humid chamber, with a
fluorescein-isothiocyanate anti-human IgG or IgM conjugate for human
samples, and a fluorescein-isothiocyanate anti-cat IgG conjugate for cat
samples [Kirkegaard and Perry Laboratories (KPL)-Europe, Milan, Italy],
diluted 1:100 in PBS containing 0.2% Evans blue (Biomerieux,
Marcy-l’Etoile, France), for 30min. The slides were washed as described
above, air dried, mounted with tamponed glycerine, and then examined
with a fluorescence microscope (Leica Microsystems, Germany) at a 40
magnification.
Serum was considered to be positive for B. henselae when the IgG titer
was 1:64 both for human and for cat samples.[15,16] Human serum was
considered positive for IgM to B. henselae when the titer was 1:20. In all
assays, a negative and a positive control was used, at known titer, and posi-
tive serum samples were titered to the maximal positive dilution.[15,16]
Statistical Analysis
Significance was tested using Student’s t-test by variance analysis
(Student–Newmann–Keuls test). Correlations between groups were per-
formed using the v2 test. The p value of <0.05 was considered as significant.
RESULTS
As shown in Table 1, of the 243 children evaluated, 61 (25.1%) had IgG
class antibodies to B. henselae. Forty-five (18.5%) showed a titer 1:64, 6
(2.4%) a titer 1:128, 6 (2.4%) a titer 1:256, 2 (0.8%) a titer 1:512, 1
(0.4%) a titer 1024, and 1 (0.4%) a titer 1:5120. Of the 122 healthy blood
donors, 14 (11.4%) had IgG class antibodies to B. henselae; 12 (9.8%) showed
a titer 1:64 and 2 (1.6%) a titer 1:128. None of the human serum samples,
both children and adults, showed positive results for IgM class antibodies
to B. henselae.
TABLE 1 Anti-B. henselae IgG Antibodies in Human Serum Samples from Sicily, Administrative
Department (Province) of Palermo, by Immunofluorescence Assay (Positive Result: 1:64)
Sera IgG Class Antibodies to B. henselae Titers (Reciprocal)
Samples Examined Positive 64 128 256 512 1024 2560 5120
Children 243 61 (25.1) 45 6 6 2 1 – 1
Blood donors 122 14 (11.4) 12 2 – – – – –
The percentage of positive sera, inside the examined groups, is shown in parentheses.
None of the human serum samples showed positive results of testing for IgM to B. henselae.
Prevalence of Antibodies Anti-Bartonella henselae 21
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Stray cats had higher seroprevalence than pet cats, and their antibody
levels were significantly higher (Table 2). In particular, of the 120 stray cats
evaluated, 82 (68.3%) had IgG class antibodies to B. henselae. Twenty-five
(20.8%) showed a titer 1:64, 17 (20.7%) a titer 1:128, 26 (31.7%) a titer
1:256, 8 (6.6%) a titer 1:512, and 6 (5.0%) a titer 1:1024. Of the 62 pet cats
evaluated, 22 (35.4%) had IgG class antibodies to B. henselae. Four (6.4%)
showed a titer 1:64, 9 (14.5%) a titer 1:128, 4 (6.4%) a titer 1:256, 3
(4.8%) a titer 1:512, 1 (1.6%) a titer 1:2560, and 1 (1.6%) a titer 1:5120.
Finally, we found significant differences between children versus healthy
blood donors (v2¼ 9.2, p< 0.01), and pet cats versus stray cats (v2¼ 17.8
p< 0.001).
DISCUSSION
The relatively low prevalence of CSD and other clinical manifestations
related to B. henselae infection contrasts with the high frequency with which
we found serologic evidence of past infection in young children. In fact,
25.1% of unselected Italian children, affected by various diseases, who were
apparently free of any clinical features suggesting B. henselae infection, had
positive results of serologic testing, which were consistent with past infec-
tion. The seroprevalence of B. henselae infection in a group of healthy blood
donors of the same geographical area was 11.4%.
B. henselae infection is common in stray and domestic cats (Felis catus).[1]
The distribution of feline infections by B. henselae and the cat flea (Ctenoce-
phalides felis) appear to be concordant, and experimental evidence has
demonstrated that cat fleas can transmit B. henselae between cats. However,
the potential role of the cat flea as a vector of CSD from cats to humans has
not been experimentally evaluated.[2] Anyway, transmission of B. henselae to
humans is obligatorily associated with feline reservoirs.[18]
Prevalence of infection varies considerably among cat populations
(strays or pets), with an increasing grading from low, in cold climates
(0% in Norway), to high, in warm and humid climates (17.02% in Brazil,
18.6% in Turkey, 68% in the Philippines).[19–21] However, inside a given
country, the prevalence may also vary among cat populations.[9,10,22,23]
TABLE 2 Anti-B. henselae IgG Antibodies in Cat Serum Samples from Sicily, Administrative Department
(Province) of Palermo, by Immunofluorescence Assay (Positive Result: 1:64)
Sera IgG class antibodies to B. henselae titers (reciprocal)
Samples Examined Positive 64 128 256 512 1024 2560 5120
Stray cats 120 82 (68.3) 25 17 26 8 6 – –
Pet cats 62 22 (35.4) 4 9 4 3 – 1
The percentage of positive sera, inside the examined groups, is shown in parentheses.
22 P. Mansueto et al.
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Seroepidemiological studies of B. henselae infection in the general
human population, especially in children, are limited in the literature. A
recent Chilean study, examining 181 children and adolescents and 107
technical and professional workers involved in the care of cats, demon-
strated a seroprevalence of B. henselae of 13.3% in children and 10.3% in
occupational risk subjects.[24] Another study, conducted in Central and
Northern Jordan, examined the sera from 482 children, and demonstrated
a seroprevalence of B. henselae of 11%, especially in those having a cat in the
household and=or having a history of cat scratches or bites.[25] An Italian
retrospective serologic study, evaluating the presence of IgG and IgM anti-
bodies to B. henselae in 508 children and adolescents, living in central Italy,
who were apparently free of any features suggesting B. henselae infection,
demonstrated an IgG seroprevalence of 61.6% and an IgM seroprevalence
of 3.9%.[12]
To our knowledge, our study is the first to evaluate a large group of
individuals—children, affected by various diseases, living in a defined
geographic area—and to relate their seroprevalence data with those from
healthy blood donors.
The high seroprevalence in children we observed could be related to
the high prevalence of this zoonosis in Sicily, as attested by a seroprevalence
of 68.3% among stray cats and of 35.4% among pet cats from the same geo-
graphic area. The different values of seroprevalences in stray cats and pet
cats may be due to the lower environmental exposure to Bartonella and
the better health state and medical surveillance of pet cats, with respect
to stray cats. However, the limitation of our survey is that our cats were ran-
domly chosen and perhaps never had a direct contact to the individuals
investigated in this study. On the other hand, the value of our study is both
in the analysis of human exposition to B. henselae and in the evaluation of
bacteria circulating in the natural reservoir.
Therefore, our data support the hypothesis that, as is true for many
other childhood infections, B. henselae infection is generally asymptomatic
in young children and, in most cases, resolves spontaneously. Only a few
subjects develop symptoms of classic CSD and systemic visceral manifesta-
tions, as a consequence of transient or stable alterations in the immunolo-
gic state,[26] but, more likely, CSD, as many other many infections, is not
diagnosed or is under-reported.
The observation of different IgG antibody titers in children (25.1%)
and in healthy blood donors (11.4%) (see Table 1) could be explained
by the fact that they decline rapidly after the exposition to B. henselae.[27]
The comparison of seroprevalences of antibodies against B. henselae and
related organisms in man and reservoir host populations is of general inter-
est, because CSD, bacillary angiomatosis, and Bartonella-induced endocar-
ditis are considered ‘‘emerging diseases.’’[21,23] Because cat populations
Prevalence of Antibodies Anti-Bartonella henselae 23
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are also reservoirs for B. clarridgeiae and B. koehlerae, in addition to B. henselae,
it would be important to include these species in further evaluation of
the seroepidemiology of Bartonella species in the cat and the human popula-
tions of our region.
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